Cargando…

Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma

Optic neuropathies such as glaucoma are characterized by retinal ganglion cell (RGC) degeneration and death. The sigma-1 receptor (S1R) is an attractive target for treating optic neuropathies as it is highly expressed in RGCs, and its absence causes retinal degeneration. Activation of the S1R exerts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geva, Michal, Gershoni-Emek, Noga, Naia, Luana, Ly, Philip, Mota, Sandra, Rego, Ana Cristina, Hayden, Michael R., Levin, Leonard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578336/ https://www.ncbi.nlm.nih.gov/pubmed/34753986 http://dx.doi.org/10.1038/s41598-021-01077-w

Ejemplares similares

Pridopidine activates neuroprotective pathways impaired in Huntington Disease
por: Geva, Michal, et al.
Publicado: (2016)

Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
por: Francardo, Veronica, et al.
Publicado: (2019)

Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine
por: Wang, Shao-Ming, et al.
Publicado: (2022)

Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1(G93A) Model
por: Ionescu, Ariel, et al.
Publicado: (2019)

Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study
por: McGarry, Andrew, et al.
Publicado: (2020)

Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose
por: Darpo, Borje, et al.
Publicado: (2023)

Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse
por: Kusko, Rebecca, et al.
Publicado: (2018)

Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses
por: Sahlholm, Kristoffer, et al.
Publicado: (2015)

Neuroprotection by Wld(S) depends on retinal ganglion cell type and age in glaucoma
por: Risner, Michael L., et al.
Publicado: (2021)

Metoprolol‐pridopidine drug–drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease
por: Rabinovich‐Guilatt, Laura, et al.
Publicado: (2017)

Pridopidine Reverses Phencyclidine-Induced Memory Impairment
por: Sahlholm, Kristoffer, et al.
Publicado: (2018)

Sigma-1R Protects Retinal Ganglion Cells in Optic Nerve Crush Model for Glaucoma
por: Li, Linya, et al.
Publicado: (2021)

Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention
por: Vernazza, Stefania, et al.
Publicado: (2021)

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [(18)F] fluspidine and [(18)F] fallypride PET study
por: Grachev, Igor D., et al.
Publicado: (2020)

Neuroprotection of Retinal Ganglion Cells Suppresses Microglia Activation in a Mouse Model of Glaucoma
por: Kumar, Sandeep, et al.
Publicado: (2023)

Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington’s Disease
por: Waters, Susanna, et al.
Publicado: (2018)

Retinal ganglion cell protection by hop-flower extract as a novel neuroprotective strategy for glaucoma
por: Hasegawa, Tomoko, et al.
Publicado: (2021)

Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
por: Lauzi, Jasmin, et al.
Publicado: (2019)

Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection
por: Enz, Tim J., et al.
Publicado: (2021)

Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma
por: Nam, Mi-Hyun, et al.
Publicado: (2022)

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
por: Stankowska, Dorota L., et al.
Publicado: (2019)

Topical and systemic GLP-1R agonist administration both rescue retinal ganglion cells in hypertensive glaucoma
por: Lawrence, Emily C. N., et al.
Publicado: (2023)

Intrinsically photosensitive retinal ganglion cells in glaucoma
por: Gao, Jingyi, et al.
Publicado: (2022)

Correction: Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
por: Stankowska, Dorota L., et al.
Publicado: (2019)

Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptor
por: Mavlyutov, Timur A., et al.
Publicado: (2011)

Sigma 1 Receptor Contributes to Astrocyte-Mediated Retinal Ganglion Cell Protection
por: Zhao, Jing, et al.
Publicado: (2022)

Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma
por: Wójcik-Gryciuk, Anna, et al.
Publicado: (2020)

Imaging of retinal ganglion cells in glaucoma: pitfalls and challenges
por: Werkmeister, R. M., et al.
Publicado: (2013)

The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease
por: Rabinovich‐Guilatt, L., et al.
Publicado: (2015)

Pridopidine modifies disease phenotype in a SOD1 mouse model of amyotrophic lateral sclerosis
por: Estévez‐Silva, Héctor M., et al.
Publicado: (2022)

Neuroprotection in glaucoma
por: Vasudevan, Sushil K, et al.
Publicado: (2011)

Neuroprotection in Glaucoma
por: Nilforushan, Naveed
Publicado: (2012)

Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016)

Neuroprotection in glaucoma
por: Vishwaraj, C R, et al.
Publicado: (2022)

Taurine Provides Neuroprotection against Retinal Ganglion Cell Degeneration
por: Froger, Nicolas, et al.
Publicado: (2012)

p58(IPK) Is an Endogenous Neuroprotectant for Retinal Ganglion Cells
por: McLaughlin, Todd, et al.
Publicado: (2018)

Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage
por: Conti, Federica, et al.
Publicado: (2021)

Diabetes accelerates retinal ganglion cell dysfunction in mice lacking sigma receptor 1
por: Ha, Yonju, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2j19epf2nj131s3gme7crp0jim